252 related articles for article (PubMed ID: 19571523)
1. [Effects of various diuretics on cardiac function in rats with heart failure].
Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of torasemide and furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Thandavarayan RA; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Feb; 75(3):649-59. PubMed ID: 18001696
[TBL] [Abstract][Full Text] [Related]
3. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Eur J Pharmacol; 2008 Feb; 581(1-2):121-31. PubMed ID: 18154949
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
Arumugam S; Sreedhar R; Karuppagounder V; Harima M; Nakamura M; Suzuki H; Sone H; Watanabe K
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28664677
[TBL] [Abstract][Full Text] [Related]
5. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
6. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
7. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Kido H; Ohtaki Y
Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
[TBL] [Abstract][Full Text] [Related]
8. [Update: prolonged-release torasemide].
Acuña C
Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
[TBL] [Abstract][Full Text] [Related]
9. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Heart; 2006 Oct; 92(10):1434-40. PubMed ID: 16621879
[TBL] [Abstract][Full Text] [Related]
10. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
11. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Liguori A; Casini A; Di Loreto M; Andreini I; Napoli C
Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906
[TBL] [Abstract][Full Text] [Related]
12. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
13. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
TORAFIC Investigators Group
Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Chetboul V; Pouchelon JL; Menard J; Blanc J; Desquilbet L; Petit A; Rougier S; Lucats L; Woehrle F;
J Vet Intern Med; 2017 Nov; 31(6):1629-1642. PubMed ID: 28975664
[TBL] [Abstract][Full Text] [Related]
15. The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
Uechi M; Matsuoka M; Kuwajima E; Kaneko T; Yamashita K; Fukushima U; Ishikawa Y
J Vet Med Sci; 2003 Oct; 65(10):1057-61. PubMed ID: 14600341
[TBL] [Abstract][Full Text] [Related]
16. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
[TBL] [Abstract][Full Text] [Related]
17. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
López B; Querejeta R; González A; Sánchez E; Larman M; Díez J
J Am Coll Cardiol; 2004 Jun; 43(11):2028-35. PubMed ID: 15172408
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Watanabe K; Sreedhar R; Thandavarayan RA; Karuppagounder V; Giridharan VV; Antony S; Harima M; Nakamura M; Suzuki K; Suzuki H; Sone H; Arumugam S
Biofactors; 2017 Mar; 43(2):187-194. PubMed ID: 27662823
[TBL] [Abstract][Full Text] [Related]
19. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
20. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
